USANA Health Sciences, Inc.

USNA Consumer Defensive Packaged Foods

USANA Health Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $925.3 million, up 8.28% from fiscal 2024. In the quarter to June 2026, revenue fell 5.33%, EPS fell 323.1% and free cash flow grew 180.6%, each against the same quarter a year earlier.

15.54 0.16 +1.04%
Market cap
$284.2M
P/E
0.0×
Fwd P/E
14.0×
Dividend yield
—
F-score
7/9
Altman Z
3.59
Beneish M
n/a
Dividend safety
70/100

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Total current assets
281.07 294.23 288.41 264.07
Total non-current assets
422.14 444.73 454.51 462.53
Total Assets
703.21 738.97 742.92 726.59
Total current liabilities
105.68 117.24 128.57 118.66
Total non-current liabilities
71.23 78.18 81.25 79.85
Total liabilities
176.90 195.42 209.81 198.52
Common Equity (Total)
526.31 543.55 533.10 528.07
Shareholders Equity (Total)
526.31 543.55 533.10 528.07

Show all line items

In millions of $ except per-share values · columns are period end dates